Hamza Suria is CEO & President at ANAPTYSBIO, INC (ANAB). They have made 12 open-market trades across 1 company since 2018, most recently 2021-12-20.
CIK 0001654495
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 12 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| ANAB | 93,330 | $4.3M |
Shares reported on the most recent Form 4, priced at the 2021-12-22 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| ANAB | SELL | 2021-12-20 | 2021-12-22 | $35.50 | $1.9M | -1.9% | -13.8% | -30.0% |
| ANAB | SELL | 2021-11-04 | 2021-11-05 | $35.00 | $713K | -14.1% | -17.2% | -18.7% |
| ANAB | SELL | 2021-11-01 | 2021-11-02 | $32.31 | $2.4M | +7.0% | +3.4% | +4.4% |
| ANAB | SELL | 2021-10-26 | 2021-10-28 | $30.00 | $480K | +7.4% | -5.9% | -3.6% |
| ANAB | SELL | 2019-06-10 | 2019-06-12 | $73.71 | $1.6M | -27.4% | -26.4% | -42.7% |
| ANAB | SELL | 2019-06-10 | 2019-06-12 | $73.74 | $2.8M | -27.4% | -26.4% | -42.7% |
| ANAB | SELL | 2019-01-14 | 2019-01-16 | $70.79 | $5.7M | -12.8% | -3.8% | +9.0% |
| ANAB | SELL | 2018-12-14 | 2018-12-18 | $69.25 | $5.2M | +3.0% | +17.5% | +17.9% |
| ANAB | SELL | 2018-12-12 | 2018-12-12 | $71.86 | $2.2M | -21.3% | +0.5% | +0.2% |
| ANAB | SELL | 2018-12-11 | 2018-12-12 | $70.83 | $354K | -21.3% | +0.5% | +0.2% |
| ANAB | SELL | 2018-12-10 | 2018-12-12 | $71.19 | $2.2M | -21.3% | +0.5% | +0.2% |
| ANAB | SELL | 2018-12-10 | 2018-12-12 | $71.50 | $9.0M | -21.3% | +0.5% | +0.2% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.